Goldhaber SZ - Search Results

1

Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.

Bell GK, Goldhaber SZ. Bell GK, et al. Among authors: goldhaber sz. Vasc Med. 2001;6(1):23-9. Vasc Med. 2001. PMID: 11358156

2

Prospective study of exogenous hormones and risk of pulmonary embolism in women.

Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. Grodstein F, et al. Among authors: goldhaber sz. Lancet. 1996 Oct 12;348(9033):983-7. doi: 10.1016/S0140-6736(96)07308-4. Lancet. 1996. PMID: 8855854

3

Clinical overview of venous thromboembolism.

Goldhaber SZ. Goldhaber SZ. Vasc Med. 1998;3(1):35-40. doi: 10.1177/1358836X9800300108. Vasc Med. 1998. PMID: 9666530 Review.

4

Frequency of pulmonary embolism in patients with low-probability lung scan and negative lower extremity venous ultrasound.

Meyerovitz MF, Mannting F, Polak JF, Goldhaber SZ. Meyerovitz MF, et al. Among authors: goldhaber sz. Chest. 1999 Apr;115(4):980-2. doi: 10.1378/chest.115.4.980. Chest. 1999. PMID: 10208195

5

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).

Goldhaber SZ, Visani L, De Rosa M. Goldhaber SZ, et al. Lancet. 1999 Apr 24;353(9162):1386-9. doi: 10.1016/s0140-6736(98)07534-5. Lancet. 1999. PMID: 10227218

6

Clinical uses of low-molecular-weight heparins.

Aguilar D, Goldhaber SZ. Aguilar D, et al. Among authors: goldhaber sz. Chest. 1999 May;115(5):1418-23. doi: 10.1378/chest.115.5.1418. Chest. 1999. PMID: 10334162 Review. No abstract available.

7

A contemporary approach to thrombolytic therapy for pulmonary embolism.

Goldhaber SZ. Goldhaber SZ. Vasc Med. 2000;5(2):115-23. doi: 10.1177/1358836X0000500208. Vasc Med. 2000. PMID: 10943588 Review.

8

Unsolved issues in the treatment of pulmonary embolism.

Goldhaber SZ. Goldhaber SZ. Thromb Res. 2001 Sep 15;103(6):V245-55. doi: 10.1016/s0049-3848(01)00325-5. Thromb Res. 2001. PMID: 11567662 Review.

9

Laboratory thrombophilias and venous thromboembolism.

Joffe HV, Goldhaber SZ. Joffe HV, et al. Among authors: goldhaber sz. Vasc Med. 2002 May;7(2):93-102. doi: 10.1191/1358863x02vm426ra. Vasc Med. 2002. PMID: 12402989 Review.

10

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators. Ridker PM, et al. Among authors: goldhaber sz. N Engl J Med. 2003 Apr 10;348(15):1425-34. doi: 10.1056/NEJMoa035029. Epub 2003 Feb 24. N Engl J Med. 2003. PMID: 12601075 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters